RAPH
RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. (RAPH)
$22
About RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. (RAPH)
Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.65
52 Week Low
$0.15
Market cap
4.3M
Dividend yield
0.00%
Volume
30
Avg. volume
65
P/E ratio
-2.99
RAPHAEL PHARMACEUTICL INC by RAPHAEL PHARMACEUTICAL INC. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$1.65
52 Week Low
$0.15
Market cap
4.3M
Dividend yield
0.00%
Volume
30
Avg. volume
65
P/E ratio
-2.99